Braze, Inc. (NASDAQ:BRZE – Get Free Report) CFO Isabelle Winkles sold 4,500 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $40.93, for a total value of $184,185.00. Following the completion of the sale, the chief financial officer now owns 258,681 shares in the company, valued at approximately $10,587,813.33. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Isabelle Winkles also recently made the following trade(s):
- On Thursday, April 11th, Isabelle Winkles sold 8,383 shares of Braze stock. The stock was sold at an average price of $42.80, for a total value of $358,792.40.
- On Friday, February 16th, Isabelle Winkles sold 5,489 shares of Braze stock. The shares were sold at an average price of $57.51, for a total transaction of $315,672.39.
Braze Price Performance
NASDAQ BRZE opened at $41.60 on Friday. The company has a fifty day simple moving average of $47.11 and a 200 day simple moving average of $50.35. Braze, Inc. has a 12-month low of $26.11 and a 12-month high of $61.53.
Hedge Funds Weigh In On Braze
A number of hedge funds have recently added to or reduced their stakes in BRZE. Principal Financial Group Inc. purchased a new stake in shares of Braze in the third quarter valued at about $4,377,000. Morgan Stanley grew its position in Braze by 20.1% in the 3rd quarter. Morgan Stanley now owns 5,387,736 shares of the company’s stock worth $251,769,000 after purchasing an additional 899,894 shares in the last quarter. Seven Eight Capital LP purchased a new stake in Braze in the 3rd quarter valued at about $283,000. Bailard Inc. lifted its position in shares of Braze by 409.7% during the 4th quarter. Bailard Inc. now owns 48,578 shares of the company’s stock worth $2,581,000 after buying an additional 39,048 shares in the last quarter. Finally, Penserra Capital Management LLC lifted its position in shares of Braze by 375.8% during the 3rd quarter. Penserra Capital Management LLC now owns 55,982 shares of the company’s stock worth $2,616,000 after buying an additional 44,217 shares in the last quarter. Institutional investors and hedge funds own 90.47% of the company’s stock.
Analyst Upgrades and Downgrades
BRZE has been the topic of a number of analyst reports. William Blair reaffirmed an “outperform” rating on shares of Braze in a research note on Thursday, March 28th. Canaccord Genuity Group decreased their price target on Braze from $65.00 to $50.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Wells Fargo & Company lowered their price objective on Braze from $75.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, April 29th. Scotiabank cut their target price on Braze from $65.00 to $58.00 and set a “sector perform” rating on the stock in a research report on Thursday, March 28th. Finally, UBS Group raised Braze from a “neutral” rating to a “buy” rating and set a $62.00 target price for the company in a research note on Thursday, March 21st. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $64.12.
Read Our Latest Stock Analysis on Braze
Braze Company Profile
Braze, Inc operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data.
Featured Articles
- Five stocks we like better than Braze
- The How and Why of Investing in Biotech Stocks
- MarketBeat Week in Review – 4/29 – 5/3
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 Monster Growth Stocks to Buy Now
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Braze Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braze and related companies with MarketBeat.com's FREE daily email newsletter.